The renal net release of the inflammatory markers IL-1ß, IL-18, and TNF-α was higher in MetS compared with Lean groups (p = 0.05, p = 0.029, and p = 0.028, respectively), but decreased after treatment with ELAM (p = 0.039, p = 0.005, and p = 0.015 vs. MetS, respectively, Figure 5). The gene discussed is IL1B; the disease is metabolic syndrome.